SCHEMBL7062480

SCHEMBL7062480

Cc1ccc(S(=O)(=O)ON(N=Cc2ccccc2F)C(=N)N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
LMNA P02545 2/20 0.43
MAPK1 P28482 1/20 0.43
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
GRIN2D O15399 2/20 0.37
GRIN3B O60391 2/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2A Q12879 2/20 0.37
GRIN2B Q13224 2/20 0.37
GRIN2C Q14957 2/20 0.37
GRIN3A Q8TCU5 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
POLB P06746 3/20 0.36
GAA P10253 2/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7065942 0.87 MAPT (0.44) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7064614 0.87 MAPT (0.44) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7065963 0.85 MAPT (0.38) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL914349 0.83 DHODH (0.41) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7062256 0.83 ALDH1A1 (0.41) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7064608 0.81 MAPT (0.44) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7065388 0.81 ATM (0.38) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7062984 0.80 MAPT (0.33) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7062996 0.79 MAPT (0.38) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL7064666 0.79 KMT2A (0.38) ALDH1A1MAPTLMNAMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP claimed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO claimed